Forecast & Rating4 analysts currently cover RenovoRx, of which 4 give a positive rating. The average price target is $7.13, about 320.4% upside from the current price of $1.70. Coverage is limited, so the data is for reference only. Data as of Aug 28, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
$7.13320.35%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met0.0%
Stock price$1.70
Avg. target$5.6
High target$13
Low target$3
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.